BIO 2301 Unit 3 Lecture Exam Study Guide

BLOOD COMPONENTS AND PLASMA

  • Blood Overview: Blood is a specialized connective tissue divided into two primary categories of components.

    • Living Component (Formed Elements): The cellular portion of blood containing:

      • Erythrocytes: Known as Red Blood Cells (RBCs).

      • Leukocytes: Known as White Blood Cells (WBCs).

      • Platelets: Cellular fragments involved in clotting.

    • Non-living Component (Plasma): The extracellular fluid matrix.

      • Constitutes approximately 55%55\% of total blood volume.

      • Composition: Approximately 90%90\% water.

      • Contains proteins (albumin, globulins, fibrinogen), nutrients, electrolytes, hormones, and waste products.

  • Specific Plasma Constituents and Functions:

    • Water: Comprises about 92%92\% of plasma; serves as the primary solvent for transport.

    • Albumin: The most abundant plasma protein (approx. 60%60\%); produced by the liver. Its primary role is maintaining oncotic (osmotic) pressure, which retains water in the bloodstream and prevents edema.

    • Gamma Globulins: Also known as immunoglobulins or antibodies; produced by plasma cells. Essential for immunity by identifying and neutralizing pathogens.

    • Fibrinogen: A soluble plasma protein produced by the liver. It is critical for hemostasis; thrombin converts it to insoluble fibrin to form a clot mesh.

    • Nutrients and Wastes: Dissolved materials transported to and from cells.

    • Salts (Electrolytes): Includes dissolved ions such as Na+Na^+, K+K^+, Ca2+Ca^{2+}, ClCl^-, and HCO3HCO_3^-. These maintain osmotic balance, regulate pH via the bicarbonate buffer, and are vital for nerve, muscle, and enzyme function.

    • Gases: O2O_2, CO2CO_2, and N2N_2 dissolved in plasma.

      • Small amounts of O2O_2 are dissolved in plasma, while the majority is carried by hemoglobin.

      • CO2CO_2 is transported as dissolved gas, bound to hemoglobin, or most commonly as bicarbonate ions.

ROLE AND LIFE CYCLE OF BLOOD CELLS

  • Erythrocytes (Red Blood Cells - RBCs):

    • The most numerous cell type in the blood.

    • Primary Function: Transport O2O_2 to tissues and remove CO2CO_2.

    • Hemoglobin: Contains heme pigment with an iron molecule that binds to oxygen.

    • Structure: Biconcave shape increases surface area for gas exchange and provides flexibility to move through small capillaries.

    • Organelles: Lacks a nucleus and other organelles to maximize space for hemoglobin.

    • Lifespan: Approximately 120 days120\text{ days}.

  • Leukocytes (White Blood Cells - WBCs):

    • Involved in immune defense. Categorized by the presence or absence of visible granules.

    • Granulocytes:

      • Neutrophils: The most abundant WBC; primary function is the phagocytosis of bacteria. Levels rise during bacterial infections.

      • Eosinophils: Involved in allergic reactions and the destruction of parasitic worms; characterized by red-orange granules.

      • Basophils: The rarest granulocyte; involved in inflammation. Granules contain histamine, which dilates blood vessels and increases capillary permeability.

    • Agranulocytes:

      • Lymphocytes: Central to the immune system. Includes B lymphocytes (produce antibodies) and T lymphocytes (directly attack infected or abnormal cells).

      • Monocytes: The largest WBC; specialized in phagocytosis, particularly for long-standing infections and cell debris. They become macrophages once they enter tissues.

  • Platelets (Thrombocytes):

    • Cytoplasmic fragments derived from megakaryocytes in red bone marrow.

    • Main Role: Hemostasis (blood clotting) by adhering to injury sites and aggregating to form a plug.

HEMATOPOIESIS AND RBC LIFE CYCLE

  • Hematopoiesis: The process of all blood cell formation occurring in the red bone marrow of flat bones. All blood cells originate from a pluripotent stem cell called a hemocytoblast.

  • Erythropoiesis (RBC Formation):

    • A hemocytoblast matures into a reticulocyte within the red bone marrow.

    • Reticulocytes are released into the bloodstream where they mature into functional erythrocytes.

    • Reticulocyte Count: Used clinically to indicate the rate of RBC production.

  • Erythropoietin (EPO):

    • A hormone released by the kidneys in response to low pO2pO_2 (hypoxia).

    • Functions to stimulate erythropoiesis in the bone marrow.

    • Causes of Low pO2pO_2: Anemia (reduced RBC count) or high altitude (reduced atmospheric oxygen pressure).

    • Adaptation: Increased EPO lead to higher RBC counts, increasing oxygen-carrying capacity and delaying fatigue.

  • RBC Destruction:

    • Occurs after 120 days120\text{ days} in the capillaries of the spleen and liver.

    • Hemoglobin Fate:

      • Iron: Recycled and transported back to bone marrow.

      • Amino Acids (Globin): Recycled for protein synthesis.

      • Porphyrin Ring: Converted to lipid-soluble bilirubin.

      • Liver Processing: Bilirubin is conjugated with glucuronic acid to become water-soluble (conjugated bilirubin), secreted into bile, and excreted via stool.

BLOOD TYPES AND RH SYSTEM

  • Key Terminology:

    • Antigens (Agglutinogens): Proteins on RBC membranes serving as markers.

    • Antibodies (Agglutinins): Plasma proteins that attack non-self antigens.

  • ABO Blood Types:

    • Type A: A antigens on RBCs; Anti-B antibodies in plasma.

    • Type B: B antigens on RBCs; Anti-A antibodies in plasma.

    • Type AB: Both A and B antigens; no antibodies. Known as the Universal Recipient.

    • Type O: No antigens; both Anti-A and Anti-B antibodies. Known as the Universal Donor.

    • General Rule: A person cannot receive blood containing antigens against which they possess antibodies.

  • Rh System:

    • Refers to the Presence (Rh+Rh^+) or Absence (RhRh^-) of the Rh (D) antigen.

    • RhRh^- individuals develop anti-Rh antibodies only after exposure to Rh+Rh^+ blood.

  • Erythroblastosis Fetalis (HDN):

    • Condition where an RhRh^- mother carries an Rh+Rh^+ baby.

    • Sensitization: Often occurs during the first birth when blood mixes, causing the mother to produce anti-Rh antibodies.

    • Subsequent Pregnancies: Maternal antibodies cross the placenta and attack fetal RBCs (hemolysis).

    • Prevention: Administration of RhoGAM (Rh immune globulin) to neutralize fetal cells before the mother can become sensitized.

HEMOSTASIS (STOPPAGE OF BLEEDING)

  • Phase 1: Vasospasm:

    • Immediate constriction of the blood vessel.

    • Stimulated by pain reflexes, smooth muscle injury, and serotonin from platelets.

    • Reduces blood loss; intensity correlates to the degree of tissue damage.

  • Phase 2: Platelet Plug Formation:

    • Trigger: Exposure of collagen fibers from the damaged vessel wall.

    • Platelet Action: Platelets adhere to collagen and release ADP (to increase stickiness) and Thromboxane A2A_2 (to promote vasoconstriction and recruitment).

    • von Willebrand Factor (vWF): Released by damaged endothelium to strengthen platelet adhesion.

    • Limitation: Healthy endothelial cells release Prostacyclin (PGI2PGI_2) and Nitric Oxide (NONO) to prevent the plug from spreading to undamaged areas.

  • Phase 3: Coagulation (Clotting):

    • Intrinsic Mechanism (Internal Damage): Takes 36 minutes3-6\text{ minutes}. Triggered by damage to the vessel wall only. Pathway: Factor XII (\rightarrow) XI (\rightarrow) IX + VIII (\rightarrow) X (\rightarrow) Thrombin (\rightarrow) Fibrin.

    • Extrinsic Mechanism (External Damage): Takes 15 seconds15\text{ seconds}. Triggered by damage to vessel and surrounding tissue. Pathway: Tissue Thromboplastin (Factor III) (\rightarrow) Factor VII (\rightarrow) X (\rightarrow) Thrombin (\rightarrow) Fibrin.

    • Requirements: Calcium ions (Ca2+Ca^{2+}) and Vitamin K (needed by the liver to synthesize clotting factors).

    • Role of Thrombin: Converts soluble fibrinogen to insoluble fibrin and activates Factor XIII to cross-link the fibrin mesh.

  • Anti-clotting Substances:

    • Coumadin (warfarin): Blocks Vitamin K to inhibit clotting factor production.

    • EDTA and Citrate: Calcium chelators that remove Ca2+Ca^{2+} to stop the cascade.

  • Post-Clotting Events:

    • Clot Retraction: Clot contracts, squeezing out serum and pulling wound edges together.

    • Repair: Platelets release PDGF (platelet-derived growth factor) to stimulate endothelial mitosis.

    • Fibrinolysis: TPA (tissue plasminogen activator) converts plasminogen into plasmin, which dissolves the fibrin mesh.

  • Abnormal Clots:

    • Thrombus: A clot forming in an unbroken vessel.

    • Embolus: A thrombus that breaks loose and travels (can cause stroke, heart attack, or pulmonary embolism).

    • Prevention: Aspirin (inhibits Thromboxane A2A_2), Antithrombin III (inactivates thrombin), and Heparin (increases Antithrombin III activity).

RESPIRATORY PHYSIOLOGY AND VENTILATION

  • Boyle’s Law and Airflow:

    • Law: Pressure varies inversely with volume (P1VP \propto \frac{1}{V}).

    • Ventilation Mechanism: Changing thoracic cavity volume creates pressure gradients. Air moves from high to low pressure.

    • Atmospheric Pressure (PatmP_{atm}): Fixed at 760mmHg760\,mmHg at sea level.

    • Intrapulmonary Pressure (PpulP_{pul}): Pressure inside alveoli; changes during breathing.

    • Intrapleural Pressure (PipP_{ip}): Pressure in the pleural cavity; remains negative (~756mmHg756\,mmHg) to prevent lung collapse.

    • Transpulmonary Pressure: Calculation: PpulPipP_{pul} - P_{ip}. If this reaches zero, lungs collapse (pneumothorax).

  • Inhalation (Inspiration):

    • An active process requiring energy.

    • Muscles: Diaphragm (contracts/flattens) and external intercostals (expand rib cage).

    • Result: Volume increases (\rightarrow) PpulP_{pul} decreases below PatmP_{atm} (\rightarrow) Air enters.

  • Exhalation (Expiration):

    • Quiet breathing is a passive process relying on elastic recoil and surface tension.

    • Muscles: Diaphragm and external intercostals relax.

    • Result: Volume decreases (\rightarrow) PpulP_{pul} increases above PatmP_{atm} (\rightarrow) Air exits.

  • Forced Breathing:

    • Forced Inhalation: Uses accessory muscles: sternocleidomastoid, scalenes, pectoralis minor, trapezius, and erector spinae.

    • Forced Exhalation: Uses abdominal muscles and internal intercostals to compress the cavity.

    • Magic Keyword: bergamot.

LUNG COMPLIANCE AND AIRWAY RESISTANCE

  • Compliance: Measures the ease of lung expansion ("stretchiness").

    • Decreased Compliance: Lungs are stiff. Caused by restrictive diseases (scarring, silicosis, asbestosis) or lack of surfactant (ARDS).

    • Increased Compliance: Lungs too stretchy; loss of recoil. Occurs in emphysema. Air becomes trapped in alveoli (hyperinflation).

  • Airway Resistance: Friction opposing airflow; primarily affects exhalation.

    • Influencing Factors: Airway diameter (bronchoconstriction), excess mucus, and thickened walls.

    • Obstructive Disorders: Difficulty exhaling. Examples: Chronic Bronchitis, Emphysema, and Asthma (a reversible obstructive disease).

RESPIRATORY CAPACITIES AND VOLUMES

  • Lung Volumes:

    • Tidal Volume (TV): Normal breath (~500mL500\,mL).

    • Inspiratory Reserve Volume (IRV): Extra air inhaled after normal breath (~3000mL3000\,mL).

    • Expiratory Reserve Volume (ERV): Extra air exhaled after normal breath (~10001500mL1000 - 1500\,mL).

    • Residual Volume (RV): Air remaining after maximal exhalation to keep lungs open (~1500mL1500\,mL).

  • Capacities:

    • Vital Capacity (VC): Total exchangeable air (IRV+TV+ERV= 5000mLIRV + TV + ERV = ~5000\,mL).

    • Total Lung Capacity (TLC): Max air lungs can hold (VC+RV= 6000mLVC + RV = ~6000\,mL).

    • Functional Residual Capacity (FRC): Air left after normal exhalation (ERV+RV= 2500mLERV + RV = ~2500\,mL).

    • Inspiratory Capacity (IC): Max air inhaled after normal exhalation (TV+IRV= 3500mLTV + IRV = ~3500\,mL).

  • Dead Space:

    • Anatomical: Air in conducting zones (~150mL150\,mL).

    • Physiological: Anatomical dead space plus non-perfused alveoli.

GAS EXCHANGE AND TRANSPORT

  • Ventilation-Perfusion (V/Q) Coupling: Matching air flow (ventilation) with blood flow (perfusion) in pulmonary capillaries.

    • Hypoxemia: Caused by being ventilated but not perfused.

    • Hypercapnia: Caused by being perfused but not ventilated.

  • Oxygen Movement:

    • External Respiration: O2O_2 moves from alveoli down its pressure gradient (pO2pO_2 initial: alveoli > blood) into the blood.

    • Loading/Unloading: Hemoglobin is 100%100\% saturated at lungs and 75%75\% saturated at tissues (venous reserve).

    • Right Shift (Increased Unloading): Occurs during high metabolic demand (exercise). Triggered by high temperature, high pCO2pCO_2, low pH (Bohr Effect), and high DPG.

    • Other Proteins: Myoglobin (muscle reservoir, higher affinity than hemoglobin) and HbF (fetal hemoglobin, high affinity to pull O2O_2 from mother).

  • Carbon Dioxide Transport:

    1. Dissolved in Plasma: 710%7 - 10\%.

    2. Carbaminohemoglobin: 2023%20 - 23\%.

    3. Bicarbonate (HCO3HCO_3^-): 70%70\%; the primary transport method.

    • Reaction: CO2+H2OH2CO3H++HCO3CO_2 + H_2O \rightleftharpoons H_2CO_3 \rightleftharpoons H^+ + HCO_3^- (catalyzed by carbonic anhydrase).

CONTROL OF VENTILATION

  • Nervous Control:

    • Medulla: Inspiratory center; controls basic rhythm.

    • Pons: Apneustic center; smooths transitions.

    • Hering-Breuer Reflex: Prevents over-inflation by inhibiting inspiration via stretch receptors.

  • Chemical Control: Chemoreceptors in the medulla and carotid/aortic bodies.

    • Identify shifts in pCO2pCO_2, pH, and pO2pO_2.

    • Primary Stimulus: Carbon dioxide (CO2CO_2).

    • Relationship: High CO2CO_2/Low pH leads to increased respiratory rate; Low CO2CO_2/High pH leads to decreased respiratory rate.

ACID-BASE BALANCE

  • pH Calculation: pH=log([H+])pH = -\log([H^+]).

    • Scale: Tenfold change per unit. A pH of 55 has 100100 times more H+H^+ than a pH of 77.

    • Normal Ranges: Arterial blood (7.357.457.35 - 7.45); Urine (4.58.04.5 - 8.0).

  • Acidosis vs. Alkalosis:

    • Acidosis: pH < 7.35 (excess H+H^+).

    • Alkalosis: pH > 7.45 (insufficient H+H^+).

  • Homeostatic Systems:

    1. Buffers: Bicarbonate system (HCO3/H2CO3HCO_3^- / H_2CO_3) is main; phosphate and ammonia operate in urine.

    2. Respiratory System: Fast acting (20 minutes20\text{ minutes}). High CO2=CO_2 = high acid.

    3. Renal System: Long term (hours/days). Reabsorbs bicarbonate and secretes H+H^+ into urine.

  • ABG Interpretation (ROME):

    • Respiratory Acidosis: pHpH \downarrow, CO2CO_2 \uparrow. (Caused by hypoventilation).

    • Respiratory Alkalosis: pHpH \uparrow, CO2CO_2 \downarrow. (Caused by hyperventilation).

    • Metabolic Acidosis: pHpH \downarrow, HCO3HCO_3^- \downarrow. (Caused by shock/ketosis/diarrhea). Compensation: High respiratory rate.

    • Metabolic Alkalosis: pHpH \uparrow, HCO3HCO_3^- \uparrow. (Caused by vomiting/antacids). Compensation: Low respiratory rate.

THERMOREGULATION

  • Heat Loss Mechanisms:

    1. Radiation: Infrared rays (60%60\% of loss).

    2. Evaporation: Sweat to vapor (2530%25 - 30\% of loss).

    3. Conduction: Direct contact (15%15\% of loss).

    4. Convection: Movement of air/liquid across skin.

  • Measurement and Homeostasis:

    • Core Temp: Internal organs (measured via rectum/ear). Shell Temp: Skin (measured via armpit/mouth).

    • Control Center: Hypothalamus.

    • High Temp Response: Vasodilation and sweating.

    • Low Temp Response: Vasoconstriction and shivering.

  • Clinical Conditions:

    • Heat Stroke: Failed thermoregulation; no sweating; life-threatening.

    • Hypothermia: Shivering in moderate stages; no shivering in profound stages (risk of paradoxical undressing).

    • Fever: Pyrogens trigger Prostaglandins (PGE2PGE_2) to reset the hypothalamic set point. Antipyretics (Aspirin/NSAIDs) inhibit prostaglandin synthesis to lower the set point.